Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.105
-0.045 (-3.91%)
Aug 7, 2025, 1:08 PM - Market open

Enveric Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2020
34342911,306
Upgrade
Market Cap Growth
-52.90%20.78%-30.19%-85.19%-99.74%-
Upgrade
Enterprise Value
-11-1-16811,308
Upgrade
Last Close Price
1.155.3819.5031.20697.503195.00
Upgrade
PB Ratio
0.732.291.540.281.313309.96
Upgrade
P/TBV Ratio
0.732.351.730.302.127223.28
Upgrade
Debt / Equity Ratio
---0.000.01-
Upgrade
Quick Ratio
3.631.501.074.438.332.32
Upgrade
Current Ratio
4.081.841.534.618.513.35
Upgrade
Return on Equity (ROE)
-178.91%-539.57%-197.47%-97.57%-380.82%-855.92%
Upgrade
Return on Assets (ROA)
-83.70%-163.09%-86.20%-53.92%-102.60%-166.96%
Upgrade
Return on Capital (ROIC)
-112.29%-339.25%-116.97%-65.48%-122.09%-299.51%
Upgrade
Earnings Yield
-327.29%-262.70%-573.01%-427.30%-167.81%-0.06%
Upgrade
FCF Yield
-264.54%-211.97%-467.23%-410.17%-39.91%-0.03%
Upgrade
Buyback Yield / Dilution
-403.24%-249.39%-49.31%-206.13%--
Upgrade
Updated Mar 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q